These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 31771896)
61. A Systematic Review of Prostatic Artery Embolization in the Treatment of Symptomatic Benign Prostatic Hyperplasia. Kuang M; Vu A; Athreya S Cardiovasc Intervent Radiol; 2017 May; 40(5):655-663. PubMed ID: 28032133 [TBL] [Abstract][Full Text] [Related]
62. Prostatic Artery Embolization Using Embosphere Microspheres for Prostates Measuring 80-150 cm(3): Early Results from a US Trial. Isaacson AJ; Raynor MC; Yu H; Burke CT J Vasc Interv Radiol; 2016 May; 27(5):709-14. PubMed ID: 27106645 [TBL] [Abstract][Full Text] [Related]
63. N-Butyl Cyanoacrylate Glue Versus Nonspherical Polyvinyl Alcohol Particles For Prostatic Arterial Embolization To Treat Benign Prostatic Hyperplasia: Safety and Efficacy. Hijazi BA; Shi HB; Liu S; Alqurashi TA; Sabri ZJ Urol J; 2023 Jul; 20(4):261-268. PubMed ID: 37330691 [TBL] [Abstract][Full Text] [Related]
64. Comparing embolic particles for prostatic artery embolization to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. Bilhim T; Vasco Costa N; Torres D; Akış S; Alves M; Papoila AL Eur Radiol; 2024 Aug; ():. PubMed ID: 39107451 [TBL] [Abstract][Full Text] [Related]
65. Using prostate contrast retention (PCR) as the procedural endpoint in prostatic artery embolization for benign prostatic hyperplasia. Hakimé A; Tun JK; Haab F; Sarrazin JL; De Baere T; Tselikas L; Kuoch V Eur Radiol; 2021 Dec; 31(12):9150-9160. PubMed ID: 34050801 [TBL] [Abstract][Full Text] [Related]
67. Initial Canadian Experience of Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: Midterm Outcomes. Patel NR; Elterman DS; Thulasidasan N; Altman R; Tai E; Zener R; Stella SF; Annamalai G; Mafeld S; Simons ME Can Assoc Radiol J; 2021 Nov; 72(4):876-882. PubMed ID: 32673069 [TBL] [Abstract][Full Text] [Related]
68. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes. Tapping CR; Little MW; Macdonald A; Mackinnon T; Kearns D; Macpherson R; Crew J; Boardman P Cardiovasc Intervent Radiol; 2021 Mar; 44(3):436-442. PubMed ID: 33210152 [TBL] [Abstract][Full Text] [Related]
69. Benefits of Repeat Prostatic Artery Embolization on Persistent or Recurrent Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia. Lehrer R; Sapoval M; Di Gaeta A; Querub C; Al Ahmar M; Dean C; Pellerin O; Boeken T Cardiovasc Intervent Radiol; 2023 Jun; 46(6):739-745. PubMed ID: 37029235 [TBL] [Abstract][Full Text] [Related]
70. Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia. Brown N; Walker D; McBean R; Pokorny M; Kua B; Gianduzzo T; Dunglison N; Esler R; Yaxley J BJU Int; 2018 Nov; 122 Suppl 5():27-34. PubMed ID: 30076682 [TBL] [Abstract][Full Text] [Related]
71. Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis. Wang XY; Zong HT; Zhang Y Clin Interv Aging; 2016; 11():1609-1622. PubMed ID: 27956827 [TBL] [Abstract][Full Text] [Related]
72. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review. Teoh JY; Chiu PK; Yee CH; Wong HM; Chan CK; Chan ES; Hou SS; Ng CF Int Urol Nephrol; 2017 Feb; 49(2):197-203. PubMed ID: 27896579 [TBL] [Abstract][Full Text] [Related]
73. Effectiveness and Safety of Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms from Benign Prostatic Hyperplasia in Men with Concurrent Localized Prostate Cancer. Parikh N; Keshishian E; Manley B; Grass GD; Torres-Roca J; Boulware D; Feuerlein S; Pow-Sang JM; Bagla S; Yamoah K; Bhatia S J Vasc Interv Radiol; 2021 Jul; 32(7):1053-1061. PubMed ID: 33794373 [TBL] [Abstract][Full Text] [Related]
74. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Pisco J; Campos Pinheiro L; Bilhim T; Duarte M; Rio Tinto H; Fernandes L; Vaz Santos V; Oliveira AG Radiology; 2013 Feb; 266(2):668-77. PubMed ID: 23204546 [TBL] [Abstract][Full Text] [Related]
75. Repeat Prostatic Artery Embolization with the Addition of a Liquid Embolic Agent: Short-term Results. Guerra X; Sapoval M; Querub C; Al Ahmar M; Di Gaeta A; Dean C; Pellerin O; Boeken T Acad Radiol; 2024 May; 31(5):1959-1967. PubMed ID: 37996363 [TBL] [Abstract][Full Text] [Related]
76. Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry. Vigneswaran G; Maclean D; Doshi N; Harris M; Bryant TJC; Hacking NC; Somani B; Modi S Cardiovasc Intervent Radiol; 2024 Jan; 47(1):115-120. PubMed ID: 38012342 [TBL] [Abstract][Full Text] [Related]
77. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600 [TBL] [Abstract][Full Text] [Related]
78. Prostatic Artery Embolization in Patients with Advanced Prostate Cancer: A Prospective Single Center Pilot Study. Burkhardt O; Abt D; Hechelhammer L; Kim O; Omlin A; Schmid HP; Engeler D; Zumstein V; Müllhaupt G Cardiovasc Intervent Radiol; 2024 Jun; 47(6):771-782. PubMed ID: 38416176 [TBL] [Abstract][Full Text] [Related]
79. Ultrasound-guided perineal laser ablation versus prostatic arterial embolization for benign prostatic hyperplasia: two similar short-term efficacies. Cai H; Zhu C; Fang J Acta Radiol; 2023 May; 64(5):2033-2039. PubMed ID: 36437581 [TBL] [Abstract][Full Text] [Related]
80. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. Bagla S; Martin CP; van Breda A; Sheridan MJ; Sterling KM; Papadouris D; Rholl KS; Smirniotopoulos JB; van Breda A J Vasc Interv Radiol; 2014 Jan; 25(1):47-52. PubMed ID: 24176946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]